寵物類固醇市場規模、佔有率和成長分析：按產品類型、配方類型、動物種類、最終用戶和地區分類－2026-2033年產業預測

2024年全球寵物類固醇市場價值為11億美元，預計將從2025年的11.8億美元成長到2033年的20.1億美元。預測期（2026-2033年）的複合年成長率預計為6.9%。

全球獸用類固醇市場的主要驅動力是伴侶動物慢性發炎和免疫介導疾病的日益增多，以及寵物飼主對獸醫護理投入的意願不斷提高。這個領域涵蓋用於抑制發炎、治療過敏和自體免疫疾病的皮質類固醇，能夠快速緩解症狀，提高寵物的生活品質，同時也帶來了穩定的處方需求。市場正從偶爾的仿單標示外用藥發展到標準化製劑、學名藥的日益普及以及線上零售通路的擴張。關鍵的成長要素包括藥物取得途徑的改善、治療模式的轉變以及寵物保險的日益普及。人工智慧技術透過預測分析和即時數據分析增強了安全性監測，從而提高了治療效率並增強了市場信心。

推動全球寵物類固醇市場發展的因素

寵物飼主對慢性發炎和內分泌疾病的認知不斷提高，促使寵物就診次數增加，藥物治療的接受度也隨之提高，從而帶動了對類固醇療法的需求。針對寵物飼主的宣傳活動、活躍的線上社群以及獸醫資訊傳播的加強，都使人們對相關症狀和類固醇療法的益處有了更深入的了解。診斷方法的進步和溝通方式的改進，促使寵物飼主更加嚴格地遵醫囑進行類固醇治療，最終提高了類固醇產品在伴侶動物醫療保健領域的市場滲透率和接受度。

全球寵物類固醇市場的限制因素

由於法規結構嚴格以及人們對動物使用類固醇的安全性日益關注，全球寵物類固醇市場面臨嚴峻挑戰。這些因素增加了產品核可和上市後監測的複雜性和成本，可能阻礙新配方的及時上市。此外，對潛在副作用、長期使用風險以及防止濫用的擔憂，使得更嚴格的標籤和監測成為必要。因此，獸醫和寵物飼主在開立和使用類固醇時往往更加謹慎。這種謹慎的態度限制了產品的日常使用量，縮小了市場產品種類，並阻礙了製造商進入該領域，即使存在明顯的臨床需求。

全球寵物類固醇市場趨勢

隨著寵物飼主越來越將寵物視為家庭成員，全球寵物類固醇市場正經歷一場重大變革時期。這推動了對個人化治療方法日益成長的需求，寵物主人也越來越希望獲得關於類固醇療法益處和使用方法的透明資訊。人們越來越傾向於選擇能夠改善寵物生活品質、促進寵物健康並減輕其壓力的配方。為了滿足這一需求，製造商正透過開發便捷的給藥方案、全面的教育資源和藥物支持計劃，不斷擴大其在高階市場的佔有率，從而滿足寵物飼主的期望並增強品牌忠誠度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球寵物類固醇市場規模：依產品類型及複合年成長率分類（2026-2033 年）

• 合成代謝類固醇
  • 注射用合成代謝藥物
  • 口服合成代謝藥物
• 皮質類固醇
  • 局部皮質類固醇
  • 注射用皮質類固醇

全球寵物類固醇市場規模：依劑型及複合年成長率分類（2026-2033 年）

• 藥片
• 液體
• 粉末

全球寵物類固醇市場規模：按動物類型和複合年成長率分類（2026-2033 年）

• 狗
• 貓
• 其他

全球寵物類固醇市場規模：按最終用戶和複合年成長率分類（2026-2033 年）

• 動物醫院
• 寵物飼主
• 寵物藥房

全球寵物類固醇市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Zoetis
• Merck Animal Health
• Elanco
• VytoMed
• PetMed Express
• Bayer Animal Health
• Ceva Animal Health
• VetEmergencies
• PetSage
• Arecibo Animal Hospital
• PetTech Pharmaceuticals
• VetBiologics
• Animal Health International
• Dechra Veterinary Products
• Vetoquinol
• ScanVet
• Neogen Corporation
• Royal Canin
• PetIQ
• Nutramax Laboratories

結論與建議

Global Steroids For Pets Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.01 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global steroids for pets market is primarily driven by the increasing prevalence of chronic inflammatory and immune-mediated conditions in companion animals, coupled with pet owners' growing willingness to invest in veterinary care. This sector includes corticosteroids used for inflammation control, allergies, and autoimmune disorders, providing rapid relief and improving pets' quality of life while fostering consistent prescription demand. The market has evolved from occasional off-label usage to standardized formulations, enhanced generic availability, and expanding online retail avenues. Key growth factors include better access to these medications, shifts in treatment paradigms, and the rise of pet insurance. AI technologies are enhancing safety monitoring through predictive analytics and real-time data analysis, thus improving treatment efficiency and increasing market confidence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Steroids For Pets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Steroids For Pets Market Segments Analysis

Global steroids for pets market is segmented by product type, formulation type, animal type, end user and region. Based on product type, the market is segmented into Anabolic Steroids and Corticosteroids. Based on formulation type, the market is segmented into Tablets, Liquid Solutions and Powdered Form. Based on animal type, the market is segmented into Dogs, Cats and Others. Based on end user, the market is segmented into Veterinary Clinics, Pet Owners and Pet Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Steroids For Pets Market

The rising awareness among pet owners regarding chronic inflammatory and endocrine disorders has resulted in an increase in veterinary visits and a growing acceptance of pharmacological treatments, which bolsters the demand for steroid therapies. Initiatives aimed at educating pet owners, active online communities, and enhanced communication from veterinarians have facilitated better recognition of symptoms and the associated benefits of steroid treatments. As diagnostic methods advance and communication improves, pet owners tend to adhere more closely to prescribed steroid regimens, ultimately leading to greater market penetration and wider acceptance of steroid products within the realm of companion animal healthcare.

Restraints in the Global Steroids For Pets Market

The Global Steroids for Pets market faces significant challenges due to stringent regulatory frameworks and heightened safety concerns surrounding steroid use in animals. These factors add complexity and elevate costs associated with product approval and post-market monitoring, which can hinder the timely introduction of new formulations. Additionally, apprehensions regarding potential adverse effects, risks linked to prolonged usage, and the possibility of misuse necessitate more rigorous labeling and oversight. Consequently, both veterinarians and pet owners tend to be more cautious in prescribing and administering steroids. This cautious approach can limit the routine use of such products, restrict the variety available in the market, and deter manufacturers from attempting to enter this segment, even in the presence of obvious clinical demand.

Market Trends of the Global Steroids For Pets Market

The Global Steroids for Pets market is witnessing a significant shift as pet owners increasingly treat their animals as integral family members, fueling a demand for personalized treatment options. This trend emphasizes the importance of individualized care, with owners seeking transparent communication regarding the benefits and administration of steroid therapies. There is a growing preference for formulations that promote wellness and minimize stress while enhancing the quality of life for pets. Consequently, manufacturers are responding by developing user-friendly dosing solutions, comprehensive educational resources, and adherence programs, positioning themselves to meet owner expectations and reinforce brand loyalty, ultimately fostering a premium market presence.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Steroids for Pets Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Anabolic Steroids
  • Injectable Anabolics
  • Oral Anabolics
• Corticosteroids
  • Topical Corticosteroids
  • Injectable Corticosteroids

Global Steroids for Pets Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Tablets
• Liquid Solutions
• Powdered Form

Global Steroids for Pets Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Others

Global Steroids for Pets Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Pet Owners
• Pet Pharmacies

Global Steroids for Pets Market Size & CAGR (2026-2033)

• North America (Product Type, Formulation Type, Animal Type, End User)
  • US
  • Canada
• Europe (Product Type, Formulation Type, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Formulation Type, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Formulation Type, Animal Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Formulation Type, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VytoMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetMed Express
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetEmergencies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetSage
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arecibo Animal Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetTech Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetBiologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Veterinary Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScanVet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal Canin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations